The synergistic effect of co-administration of Berberine/ Sitagliptin may have a better therapeutic effect, reducing hyperinsulinemia and fasting blood sugar, and improving insulin sensitivity in rats, suggesting a role in improving insulin resistance in NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.